We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Avacta Group PLC 09 April 2024 This...
Avacta Group PLC 08 April 2024 ...
Avacta Group - AVA6000 Abstract Release by AACR and Full Presentation Update 5 April 2024 Avacta Group plc(“Avacta” or “the Group” or “the Company”) AVA6000 Abstract Release by AACR and...
Avacta Group PLC 28 March 2024 March...
Avacta Group PLC on Thursday said it dosed the third patient in the first cohort of its phase 1a dose escalation stud ...
Avacta Group PLC 21 March 2024 This...
- Wetherby, England-based life sciences company developing oncology drugs and diagnostics - At annual general meeting ...
Avacta Group PLC 18 March 2024 THIS ANNOUNCEMENT IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED...
Avacta Group PLC 06 March 2024 6 March 2024 Avacta Group plc ("Avacta" or "the Group" or "the Company") Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug...
5 March 2024 Avacta Group plc (“Avacta” or “the Group” or “the Company”) Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -3.25 | -6.28019323671 | 51.75 | 52.25 | 45.75 | 2070138 | 50.08328672 | DE |
4 | -4.75 | -8.92018779343 | 53.25 | 57 | 45.75 | 3203281 | 51.51096945 | DE |
12 | -53 | -52.2167487685 | 101.5 | 109 | 45.75 | 3173501 | 61.61673968 | DE |
26 | -90.5 | -65.1079136691 | 139 | 151.5 | 45.75 | 2199328 | 83.15370401 | DE |
52 | -81 | -62.5482625483 | 129.5 | 166.5 | 45.75 | 1790372 | 96.79565596 | DE |
156 | -198.5 | -80.3643724696 | 247 | 290 | 38.5 | 1926268 | 119.9000243 | DE |
260 | 15.25 | 45.8646616541 | 33.25 | 290 | 13.5 | 2380798 | 121.94391314 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions